ANO1 and neoplasm: In pancreatic cancer, ANO1 influences the TME through cytokine and interleukin signaling, promoting fibroblast accumulation and reducing CD8+ T cell infiltration via paracrine signaling, thereby creating a TME that facilitates tumor growth and immune evasion (31).